Close Menu

BMS

Opko Health last week presented data at the Alzheimer's Association International Conference in Vancouver demonstrating that its antibody-based Alzheimer's diagnostic identified cases of the disease with 100 percent specificity in a set of 36 autopsy-confirmed plasma samples.

NEW YORK (GenomeWeb News) – Qiagen announced after the close of the market on Friday that the US Food and Drug Administration has cleared for marketing its therascreen KRAS RGQ PCR Kit to be sold as a companion diagnostic test for Erbitux (cetuximab), a drug used for treating colorectal cancer.

The American Society of Clinical Oncology held its annual meeting June 1-5 in Chicago. The following are abstracts presented at the meeting focused on pharmacogenomically guided treatment strategies.

Eli Lilly said last week that it received a complete response letter from the US Food and Drug Administration declining its application to market Erbitux as a first-line treatment for non-small cell lung cancer.

By Adam Bonislawski
Researchers at Australia's University of Newcastle have published one of the first analyses of data from the Alzheimer's Disease Neuroimaging Initiative's plasma proteome project.

This article was originally posted March 29.
The annual meeting of the American College of Cardiology held last week in Chicago featured a number of pharmacogenomically guided studies related to treatments for cardiovascular disease.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bristol-Myers Squibb and Meso Scale Discovery today announced a deal to develop assays for use in Alzheimer's disease research.

By Monica Heger

Despite being the third best-selling drug in 2010, as many as one-third of cardiology patients do not respond to Bristol-Myers Squibb's blood-thinning drug Plavix (clopidogrel).

Pages

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.